Ironwood Pharmaceuticals Inc’s recent filing unveils that its Chief Legal Officer John Minardo unloaded Company’s shares for reported $42316.0 on Aug 12 ’24. In the deal valued at $4.27 per share,9,910 shares were sold. As a result of this transaction, John Minardo now holds 284,661 shares worth roughly $1.18 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Silver Ronald sold 3,107 shares, generating $13,267 in total proceeds. Upon selling the shares at $4.27, the Principal Accounting Officer now owns 158,370 shares.
Before that, John Minardo bought 11,726 shares. Ironwood Pharmaceuticals Inc shares valued at $47,490 were divested by the Officer at a price of $4.05 per share.
Leerink Partners initiated its Ironwood Pharmaceuticals Inc [IRWD] rating to a Market perform in a research note published on September 09, 2024; the price target was $5. A number of analysts have revised their coverage, including CapitalOne’s analysts, who decreased its forecast for the stock in early August from “an Overweight” to “an Equal weight”. Craig Hallum began covering IRWD with “Buy” recommendation on January 17, 2024. Wells Fargo started covering the stock on December 14, 2023. It rated IRWD as “an Overweight”.
Price Performance Review of IRWD
On Monday, Ironwood Pharmaceuticals Inc [NASDAQ:IRWD] saw its stock jump 4.80% to $4.15. Over the last five days, the stock has lost -0.95%. Ironwood Pharmaceuticals Inc shares have fallen nearly -63.72% since the year began. Nevertheless, the stocks have fallen -53.99% over the past one year. While a 52-week high of $15.70 was reached on 02/14/24, a 52-week low of $3.79 was recorded on 08/08/24. SMA at 50 days reached $4.40, while 200 days put it at $7.57.
Levels Of Support And Resistance For IRWD Stock
The 24-hour chart illustrates a support level at 4.02, which if violated will result in even more drops to 3.90. On the upside, there is a resistance level at 4.32. A further resistance level may holdings at 4.49. The Relative Strength Index (RSI) on the 14-day chart is 46.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.22%. Stochastics %K at 20.00% indicates the stock is a holding.
How much short interest is there in Ironwood Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ironwood Pharmaceuticals Inc stocks on 2024-10-15, growing by 0.32 million shares to a total of 11.93 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 11.61 million shares. There was a rise of 2.66%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on November 09, 2023 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
